SSA
BIO icon

Schonfeld Strategic Advisors’s Bio-Rad Laboratories Class A BIO Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$1.44M Buy
5,970
+1,540
+35% +$372K 0.01% 1070
2025
Q1
$1.08M Buy
+4,430
New +$1.08M 0.01% 1145
2024
Q4
Sell
-1,400
Closed -$468K 1935
2024
Q3
$468K Buy
1,400
+46
+3% +$15.4K ﹤0.01% 1331
2024
Q2
$370K Buy
+1,354
New +$370K ﹤0.01% 1467
2024
Q1
Sell
-1,500
Closed -$484K 1884
2023
Q4
$484K Buy
1,500
+478
+47% +$154K ﹤0.01% 1220
2023
Q3
$366K Sell
1,022
-49,986
-98% -$17.9M ﹤0.01% 1161
2023
Q2
$19.3M Sell
51,008
-166,802
-77% -$63.2M 0.17% 181
2023
Q1
$104M Buy
217,810
+36,371
+20% +$17.4M 1% 2
2022
Q4
$76.3M Buy
181,439
+6,417
+4% +$2.7M 0.64% 14
2022
Q3
$73M Sell
175,022
-132,806
-43% -$55.4M 0.61% 7
2022
Q2
$152M Buy
307,828
+142,870
+87% +$70.7M 1.48% 1
2022
Q1
$92.9M Sell
164,958
-5,436
-3% -$3.06M 0.84% 4
2021
Q4
$129M Sell
170,394
-14,772
-8% -$11.2M 1.17% 2
2021
Q3
$138M Buy
185,166
+68,849
+59% +$51.4M 1.43% 1
2021
Q2
$74.9M Sell
116,317
-6,940
-6% -$4.47M 0.8% 6
2021
Q1
$70.4M Buy
123,257
+27,809
+29% +$15.9M 0.86% 6
2020
Q4
$55.6M Buy
95,448
+59,550
+166% +$34.7M 0.75% 12
2020
Q3
$18.5M Sell
35,898
-1,569
-4% -$809K 0.35% 47
2020
Q2
$16.9M Buy
37,467
+7,841
+26% +$3.54M 0.43% 36
2020
Q1
$10.4M Sell
29,626
-73,235
-71% -$25.7M 0.65% 18
2019
Q4
$38.1M Buy
102,861
+21,202
+26% +$7.85M 0.93% 15
2019
Q3
$27.2M Buy
81,659
+22,072
+37% +$7.34M 0.8% 15
2019
Q2
$18.6M Buy
59,587
+42,387
+246% +$13.2M 0.66% 22
2019
Q1
$5.26M Buy
17,200
+8,402
+95% +$2.57M 0.18% 147
2018
Q4
$2.04M Buy
8,798
+2,798
+47% +$650K 0.08% 323
2018
Q3
$1.88M Sell
6,000
-31,512
-84% -$9.86M 0.08% 296
2018
Q2
$10.8M Buy
37,512
+35,989
+2,363% +$10.4M 0.59% 18
2018
Q1
$381K Sell
1,523
-3,341
-69% -$836K 0.03% 526
2017
Q4
$1.16M Buy
+4,864
New +$1.16M 0.1% 277
2017
Q2
Sell
-1,472
Closed -$294K 595
2017
Q1
$294K Sell
1,472
-1,730
-54% -$346K 0.03% 475
2016
Q4
$584K Buy
+3,202
New +$584K 0.08% 311
2016
Q2
Sell
-2,259
Closed -$309K 436
2016
Q1
$309K Buy
+2,259
New +$309K 0.13% 216